Product Program year 2025 Source: CMS Open Payments

Eloctate

Biological Hematology

NDC 71104-801-01

Open in the dashboard

General payments

$453,740

557 payments

Research payments

$600,743

276 payments

Through program year 2025, $453,740 in general payments and $600,743 in research payments were reported against Eloctate (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

11 rows
Year Kind Amount Payments
2025 General $9,185 16
2024 General $42,584 77
2024 Research $1,250 1
2023 General $9,666 29
2023 Research $2,000 3
2022 General $182,393 222
2022 Research $57,219 9
2021 General $75,730 99
2021 Research $228,666 115
2020 General $134,183 114
2020 Research $311,608 148

Breakdown

Who paid General payments · program years 2020–2025
  1. Genzyme Corporation $385,494 507 payments
  2. Bioverativ Therapeutics Inc. $39,224 27 payments
  3. Sanofi-Aventis U.S. LLC $29,022 23 payments
Top recipients General payments · program year 2025
  1. Michael Guerrera Pediatric Hematology-Oncology · Washington, DC $8,757 95% · 2 payments
  2. Drew Oostra Hematology & Oncology · Toledo, OH $77 <1% · 2 payments
  3. Dagmar Stein Pediatrics · Toledo, OH $37 <1% · 1 payment
  4. Abigail Coulter Physician Assistant · Sylvania, OH $37 <1% · 1 payment
  5. Ashley Wehrle Physician Assistant · Pittsburgh, PA $31 <1% · 1 payment

The top 5 of 14 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Hematology-Oncology Pediatrics $8,841 96% · 4 practitioners
  2. Pediatrics $98 1% · 3 practitioners
  3. Hematology & Oncology Internal Medicine $77 <1% · 1 practitioner
  4. Physician Assistant $68 <1% · 2 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $47 <1% · 2 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. District of Columbia $8,757 95% · 1 recipient
  2. Michigan $185 2% · 7 recipients
  3. Ohio $151 2% · 3 recipients
  4. Pennsylvania $31 <1% · 1 recipient
  5. Kansas $30 <1% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to ELOCTATE
Billing code Providers Services Paid by Medicare
Injection, factor viii fc fusion protein (recombinant), per iu J7205 1 1,343,306 $2,314,381

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

557 general · 276 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record